Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

Table of Contents

March 01, 2016; Volume 43,Issue 3

Editorials

  • You have access
    Is There a Future for Interleukin 17 Blocking Agents in Rheumatoid Arthritis?
    PATRICK DUREZ
    The Journal of Rheumatology March 1 2016, 43 (3) 465-467; DOI: https://doi.org/10.3899/jrheum.160010
  • You have access
    Spondyloarthritis. Clinical Versus Imaging Assessment: And the Winner Is?
    DANIEL WENDLING, SÉBASTIEN AUBRY and CLÉMENT PRATI
    The Journal of Rheumatology March 1 2016, 43 (3) 468-470; DOI: https://doi.org/10.3899/jrheum.151341
  • You have access
    Do Biologic-treated Psoriatic Arthritis Patients with Spondylitis Respond Differently with or without Concomitant Methotrexate from Patients without Spondylitis?
    PHILIP J. MEASE
    The Journal of Rheumatology March 1 2016, 43 (3) 471-473; DOI: https://doi.org/10.3899/jrheum.160046

Articles

  • You have access
    GREM1 Is a Key Regulator of Synoviocyte Hyperplasia and Invasiveness
    Eun-Jin Han, Seung-Ah Yoo, Gi-Myo Kim, Daehee Hwang, Chul-Soo Cho, Sungyong You and Wan-Uk Kim
    The Journal of Rheumatology March 1 2016, 43 (3) 474-485; DOI: https://doi.org/10.3899/jrheum.150523
  • You have access
    The Framingham Score and the Systematic Coronary Risk Evaluation at Low Cutoff Values Are Useful Surrogate Markers of High-risk Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
    Patrick H. Dessein, Alfonso Corrales, Raquel Lopez-Mejias, Ahmed Solomon, Angela J. Woodiwiss, Javier Llorca, Gavin R. Norton, Fernanda Genre, Ricardo Blanco, Trinitario Pina, Carlos Gonzalez-Juanatey, Linda Tsang and Miguel A. Gonzalez-Gay
    The Journal of Rheumatology March 1 2016, 43 (3) 486-494; DOI: https://doi.org/10.3899/jrheum.150510
  • You have access
    Efficacy and Safety of Subcutaneous and Intravenous Loading Dose Regimens of Secukinumab in Patients with Active Rheumatoid Arthritis: Results from a Randomized Phase II Study
    Witold Tlustochowicz, Proton Rahman, Bruno Seriolo, Gerhard Krammer, Brian Porter, Albert Widmer and Hanno B. Richards
    The Journal of Rheumatology March 1 2016, 43 (3) 495-503; DOI: https://doi.org/10.3899/jrheum.150117
  • Open Access
    Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-week, Double-blind, Randomized Placebo-controlled Study
    Yoshiya Tanaka, Kahaku Emoto, Zhihong Cai, Takehiro Aoki, Douglas Schlichting, Terence Rooney and William Macias
    The Journal of Rheumatology March 1 2016, 43 (3) 504-511; DOI: https://doi.org/10.3899/jrheum.150613
  • You have access
    The Rate of Adherence to Antiarthritis Medications and Associated Factors among Patients with Rheumatoid Arthritis: A Systematic Literature Review and Metaanalysis
    Anat Scheiman-Elazary, Lewei Duan, Courtney Shourt, Harsh Agrawal, David Ellashof, M. Cameron-Hay and Daniel E. Furst
    The Journal of Rheumatology March 1 2016, 43 (3) 512-523; DOI: https://doi.org/10.3899/jrheum.141371
  • You have access
    Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor-α Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence
    Bunyamin Kisacik, Omer Nuri Pamuk, Ahmet Mesut Onat, Sait Burak Erer, Gulen Hatemi, Yesim Ozguler, Yavuz Pehlivan, Levent Kilic, Ihsan Ertenli, Meryem Can, Haner Direskeneli, Gökhan Keser, Fahrettin Oksel, Ediz Dalkilic, Sedat Yilmaz, Salih Pay, Ayse Balkarli, Veli Cobankara, Gözde Yildirim Cetin, Mehmet Sayarlioglu, Ayse Cefle, Ayten Yazici, Ali Berkant Avci, Ender Terzioglu, Suleyman Ozbek, Servet Akar and Ahmet Gul
    The Journal of Rheumatology March 1 2016, 43 (3) 524-529; DOI: https://doi.org/10.3899/jrheum.150177
  • Open Access
    Development of System-level Performance Measures for Evaluation of Models of Care for Inflammatory Arthritis in Canada
    Claire E.H. Barber, Deborah A. Marshall, Dianne P. Mosher, Pooneh Akhavan, Lori Tucker, Kristin Houghton, Michelle Batthish, Deborah M. Levy, Heinrike Schmeling, Janet Ellsworth, Heidi Tibollo, Sean Grant, Dmitry Khodyakov, Diane Lacaille and The Arthritis Alliance of Canada Performance Measurement Development Panel
    The Journal of Rheumatology March 1 2016, 43 (3) 530-540; DOI: https://doi.org/10.3899/jrheum.150839
  • You have access
    Genetic Variants That Are Associated with Neuropsychiatric Systemic Lupus Erythematosus
    Roger C. Ho, Huiyi Ong, Chandra Thiaghu, Yanxia Lu, Cyrus S. Ho and Melvyn W. Zhang
    The Journal of Rheumatology March 1 2016, 43 (3) 541-551; DOI: https://doi.org/10.3899/jrheum.150884
  • You have access
    Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study
    Konstantinos Tselios, Dafna D. Gladman, Jiandong Su and Murray B. Urowitz
    The Journal of Rheumatology March 1 2016, 43 (3) 552-558; DOI: https://doi.org/10.3899/jrheum.150779
  • You have access
    Clinical Features, Morbidity, and Risk Factors of Intestinal Pseudo-obstruction in Systemic Lupus Erythematosus: A Retrospective Case-control Study
    Lingling Zhang, Dong Xu, Hong Yang, Xinping Tian, Qian Wang, Yong Hou, Na Gao, Li Zhang, Mengtao Li and Xiaofeng Zeng
    The Journal of Rheumatology March 1 2016, 43 (3) 559-564; DOI: https://doi.org/10.3899/jrheum.150074
  • You have access
    Predictors of Incident Seizure in Systemic Lupus Erythematosus
    XiangYang Huang, Laurence S. Magder and Michelle Petri
    The Journal of Rheumatology March 1 2016, 43 (3) 565-575; DOI: https://doi.org/10.3899/jrheum.150135
  • You have access
    Venous and Arterial Thrombotic Events in Systemic Lupus Erythematosus
    Andrea Hinojosa-Azaola, Juanita Romero-Diaz, Angel Gabriel Vargas-Ruiz, Carlos A. Nuñez-Alvarez, Alba Cicero-Casarrubias, Mario C. Ocampo-Torres and Jorge Sanchez-Guerrero
    The Journal of Rheumatology March 1 2016, 43 (3) 576-586; DOI: https://doi.org/10.3899/jrheum.150506
  • You have access
    Monocytic Angiotensin and Endothelin Receptor Imbalance Modulate Secretion of the Profibrotic Chemokine Ligand 18
    Judith Rademacher, Angela Kill, Kathrin Mattat, Duska Dragun, Elise Siegert, Jeannine Günther and Gabriela Riemekasten
    The Journal of Rheumatology March 1 2016, 43 (3) 587-591; DOI: https://doi.org/10.3899/jrheum.150474
  • You have access
    Assessment, Definition, and Classification of Lower Limb Ulcers in Systemic Sclerosis: A Challenge for the Rheumatologist
    Jelena Blagojevic, Guya Piemonte, Laura Benelli, Francesca Braschi, Ginevra Fiori, Francesca Bartoli, Serena Guiducci, Silvia Bellando Randone, Felice Galluccio, Laura Cometi, Sergio Castellani, Maria Boddi, Alberto Moggi Pignone, Laura Rasero, Francesco Epifani and Marco Matucci-Cerinic
    The Journal of Rheumatology March 1 2016, 43 (3) 592-598; DOI: https://doi.org/10.3899/jrheum.150035
  • You have access
    Quantitative Alterations of Capillary Diameter Have a Predictive Value for Development of the Capillaroscopic Systemic Sclerosis Pattern
    Amelia Chiara Trombetta, Vanessa Smith, Carmen Pizzorni, Marianna Meroni, Sabrina Paolino, Caterina Cariti, Barbara Ruaro, Alberto Sulli and Maurizio Cutolo
    The Journal of Rheumatology March 1 2016, 43 (3) 599-606; DOI: https://doi.org/10.3899/jrheum.150900
  • You have access
    Nonsteroidal Antiinflammatory Drugs for Axial Spondyloarthritis: A Cochrane Review
    Féline P.B. Kroon, Lennart R.A. van der Burg, Sofia Ramiro, Robert B.M. Landewé, Rachelle Buchbinder, Louise Falzon and Désirée van der Heijde
    The Journal of Rheumatology March 1 2016, 43 (3) 607-617; DOI: https://doi.org/10.3899/jrheum.150721
  • You have access
    Comparison of Clinical Examination versus Whole-body Magnetic Resonance Imaging of Enthesitis in Patients with Early Axial Spondyloarthritis during 3 Years of Continuous Etanercept Treatment
    Christian E. Althoff, Joachim Sieper, In-Ho Song, Anja Weiß, Torsten Diekhoff, Hildrun Haibel, Bernd Hamm and Kay-Geert A. Hermann
    The Journal of Rheumatology March 1 2016, 43 (3) 618-624; DOI: https://doi.org/10.3899/jrheum.150659
  • You have access
    Risk of Psychiatric Disorders following Ankylosing Spondylitis: A Nationwide Population-based Retrospective Cohort Study
    Cheng-Che Shen, Li-Yu Hu, Albert C. Yang, Benjamin Ing-Tiau Kuo, Yung-Yen Chiang and Shih-Jen Tsai
    The Journal of Rheumatology March 1 2016, 43 (3) 625-631; DOI: https://doi.org/10.3899/jrheum.150388
  • Open Access
    Does Concomitant Methotrexate with Adalimumab Influence Treatment Outcomes in Patients with Psoriatic Arthritis? Data from a Large Observational Study
    Frank Behrens, Michaela Koehm, Uta Arndt, Bianca M. Wittig, Gerd Greger, Diamant Thaçi, Eva Scharbatke, Hans-Peter Tony and Harald Burkhardt
    The Journal of Rheumatology March 1 2016, 43 (3) 632-639; DOI: https://doi.org/10.3899/jrheum.141596
  • You have access
    Incremental Costs for Psoriasis and Psoriatic Arthritis in a Population-based Cohort in Southern Sweden: Is It All Psoriasis-attributable Morbidity?
    Sofia Löfvendahl, Ingemar F. Petersson, Elke Theander, Åke Svensson, Caddie Zhou and Katarina Steen Carlsson
    The Journal of Rheumatology March 1 2016, 43 (3) 640-647; DOI: https://doi.org/10.3899/jrheum.150406
  • You have access
    Severe Intracranial Involvement in Giant Cell Arteritis: 5 Cases and Literature Review
    Roaa S. Alsolaimani, Sankalp V. Bhavsar, Nader A. Khalidi, Christian Pagnoux, Jennifer L. Mandzia, KengYeow Tay and Lillian J. Barra
    The Journal of Rheumatology March 1 2016, 43 (3) 648-656; DOI: https://doi.org/10.3899/jrheum.150143
  • You have access
    High Kellgren-Lawrence Grade and Bone Marrow Lesions Predict Worsening Rates of Radiographic Joint Space Narrowing; The SEKOIA Study
    Mark H. Edwards, Camille Parsons, Olivier Bruyère, Forence Petit Dop, Roland Chapurlat, Frank W. Roemer, Ali Guermazi, Souhil Zaim, Harry Genant, Jean-Yves Reginster, Elaine M. Dennison, Cyrus Cooper and The SEKOIA Study Group
    The Journal of Rheumatology March 1 2016, 43 (3) 657-665; DOI: https://doi.org/10.3899/jrheum.150053
  • You have access
    Improved Function and Reduced Pain after Swimming and Cycling Training in Patients with Osteoarthritis
    Mohammed Alkatan, Jeffrey R. Baker, Daniel R. Machin, Wonil Park, Amanda S. Akkari, Evan P. Pasha and Hirofumi Tanaka
    The Journal of Rheumatology March 1 2016, 43 (3) 666-672; DOI: https://doi.org/10.3899/jrheum.151110

Images in Rheumatology

  • You have access
    Sacroiliitis-like Changes in 2 Patients with Spina Bifida
    JONATHAN CHAN, ISMAIL SARI and NIGIL HAROON
    The Journal of Rheumatology March 1 2016, 43 (3) 673; DOI: https://doi.org/10.3899/jrheum.150980
  • You have access
    Subcutaneous Sarcoidosis Mimicking Cellulitis
    KYU YEOUN WON, SO YOUNG PARK and SANG-HOON LEE
    The Journal of Rheumatology March 1 2016, 43 (3) 674-675; DOI: https://doi.org/10.3899/jrheum.151030

Correspondence

  • You have access
    Systemic Sclerosis and Outcome in Intensive Care Unit: Do Not Close the Door, Open the Right Protocol
    PAOLA FAVERIO, ALBERTO PESCI and ANTONIO M. ESQUINAS
    The Journal of Rheumatology March 1 2016, 43 (3) 676-677; DOI: https://doi.org/10.3899/jrheum.151057
  • You have access
    Dr. Pène, et al reply
    FRÉDÉRIC PÈNE, YANNICK ALLANORE and LUC MOUTHON
    The Journal of Rheumatology March 1 2016, 43 (3) 677; DOI: https://doi.org/10.3899/jrheum.151335
  • You have access
    Assessment of Serum Uric Acid in Young Male Patients with Ankylosing Spondylitis
    TOLGA DOGAN and MEHMET AGILLI
    The Journal of Rheumatology March 1 2016, 43 (3) 678; DOI: https://doi.org/10.3899/jrheum.150577
  • You have access
    Drs. Kang and Ju reply
    KWI YOUNG KANG and JI HYEON JU
    The Journal of Rheumatology March 1 2016, 43 (3) 678; DOI: https://doi.org/10.3899/jrheum.151268

Letter

  • You have access
    Genetic Markers in a Medieval Case of Ankylosing Spondylitis
    IMANOL MARTÍN LAZA, MONTSERRAT HERVELLA and CONCEPCIÓN DE-LA-RÚA
    The Journal of Rheumatology March 1 2016, 43 (3) 679-681; DOI: https://doi.org/10.3899/jrheum.151170

Corrections

  • You have access
    Specific Antinuclear Antibody Level Changes after B Cell Depletion Therapy in Systemic Sclerosis Are Associated with Improvement of Skin Thickening
    The Journal of Rheumatology March 1 2016, 43 (3) 681; DOI: https://doi.org/10.3899/jrheum.150105.C1
  • You have access
    Risk of Venous Thromboembolism after Total Knee Arthroplasty in Patients with Rheumatoid Arthritis
    The Journal of Rheumatology March 1 2016, 43 (3) 681; DOI: https://doi.org/10.3899/jrheum.140768.C1
Back to top
PreviousNext

In this issue

The Journal of Rheumatology
Vol. 43, Issue 3
1 Mar 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)

Jump to

  • Editorials
  • Articles
  • Images in Rheumatology
  • Correspondence
  • Letter
  • Corrections
  • Most Read
  • ​ Editor's Picks
  • E-letters
Loading
  • Effects of Bedtime Very Low Dose Cyclobenzaprine on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome: A Double-blind Randomized Placebo-controlled Study
  • Extravascular Necrotizing Granuloma: A Diagnostic Clue for Eosinophilic Granulomatosis With Polyangiitis
  • Immunoglobulin A Vasculitis Following COVID-19: A French Multicenter Case Series
  • Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines
  • Melorheostosis or “Dripping Candle Wax” Bone Disease
More...

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire